Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals plc | 3,931,818 | 3,931,818 | 0 | $62.87M | $65.86M | 45.01% | +$2.99M |
| Tectonic Therapeutic, Inc.(TECX) | 1,028,674 | 1,028,674 | 0 | $31.17M | $47.49M | 32.46% | +$16.33M |
| Kyverna Therapeutics, Inc.(KYTX) | 4,523,924 | 4,523,924 | 0 | $22.12M | $16.92M | 11.56% | -$5.20M |
| Dyne Therapeutics, Inc.(DYN) | 407,499 | 407,499 | 0 | $14.64M | $9.60M | 6.56% | -$5.04M |
| Allogene Therapeutics, Inc. | 1,798,163 | 1,798,163 | 0 | $5.03M | $3.83M | 2.62% | -$1.20M |
| Kronos Bio, Inc. | 2,765,314 | 2,765,314 | 0 | $2.77M | $2.63M | 1.80% | -$138.3K |